A hard lump may indicate lipohypertrophy or a reaction to repeated injections in that area
MK-677 is more likely to cause lethargy, particularly in the first weeks of use
Medication Interactions That Could Amplify Mood Changes Some medications can interact with semaglutide and increase the risk of irritability
Based on your responses, they determine whether a GLP-1 treatment such as semaglutide or tirzepatide is appropriate for you
Administered as a once-weekly subcutaneous injection, Mounjaro offers a treatment option for individuals whose diabetes is inadequately controlled with diet, exercise, and other oral antidiabetic medications
10 This medicine was registered in October, 2013, and is expected to be available (unsubsidised) in New Zealand in February, 2014